Artículo Destacado en trastornos del movimiento

Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group

Garcia-Delgar B, Servera M, Coffey BJ, Lázaro L, Openneer T, Benaroya-Milshtein N, Steinberg T, Hoekstra PJ, Dietrich A, Morer A; EMTICS collaborative group.

Eur Child Adolesc Psychiatry. 2022 Oct;31(10):1539-1548. doi: 10.1007/s00787-021-01751-4. Epub 2021 May 4.

Proof of Concept Study of an Oral Orthotic in Reducing Tic Severity in Tourette Syndrome

Bennett SM, Hindin JS, Mohatt J, Bauer C, Schild J, Falk A, Specht M, Woods D, Walkup J.

Child Psychiatry Hum Dev. 2022 Oct;53(5):953-963. doi: 10.1007/s10578-021-01178-7. Epub 2021 May 6.

The changing landscape of childhood tic disorders following COVID-19

Horner O, Hedderly T, Malik O.

Paediatr Child Health (Oxford). 2022 Oct;32(10):363-367. doi: 10.1016/j.paed.2022.07.007. Epub 2022 Aug 9.

Tics: neurological disorders determined by a deficit in sensorimotor gating processes

Schilke ED, Tremolizzo L, Appollonio I, Ferrarese C.

Neurol Sci. 2022 Oct;43(10):5839-5850. doi: 10.1007/s10072-022-06235-0. Epub 2022 Jul 4.

Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review

Oikonomou P, Jost WH.

J Neural Transm (Vienna). 2022 Oct;129(10):1247-1256. doi: 10.1007/s00702-022-02529-x. Epub 2022 Jul 20.

Impact of ADHD and OCD in Portuguese and Brazilian Patients with Tourette Syndrome During the COVID-19 Pandemic

Araújo AI, Carneiro F, Conceição V, Pereira AT, Macedo A.

Acta Med Port. 2022 Oct 3;35(10). doi: 10.20344/amp.18426. Epub 2022 Aug 26.

Why Tic Severity Changes from Then to Now and from Here to There

Iverson AM, Black KJ.

J Clin Med. 2022 Oct 8;11(19):5930. doi: 10.3390/jcm11195930.

Comparison of efficacy of deep brain stimulation, repeat transcranial magnetic stimulation, and behavioral therapy in Tourette syndrome: A systematic review and Bayesian Network Meta-Analysis

Lin X, Lin F, Chen H, Weng Y, Wen J, Ye Q, Chen C, Cai G.

Heliyon. 2022 Oct 10;8(10):e10952. doi: 10.1016/j.heliyon.2022.e10952. eCollection 2022 Oct.

The role of cannabinoids in neurodevelopmental disorders of children and adolescents

Dias-de Freitas F, Pimenta S, Soares S, Gonzaga D, Vaz-Matos I, Prior C.

Rev Neurol. 2022 Oct 1;75(7):189-197. doi: 10.33588/rn.7507.2022123.

Evaluation of EEG biomarkers of Comprehensive Behavioral Intervention for Tics in children with Tourette syndrome

Morand-Beaulieu S, Crowley MJ, Grantz H, Leckman JF, Scahill L, Sukhodolsky DG.

Clin Neurophysiol. 2022 Oct;142:75-85. doi: 10.1016/j.clinph.2022.07.500. Epub 2022 Aug 4.

Addressing co-occurring conditions in behavioural therapy for tic disorders: a review and guideline

Sanderson C, Verdellen C, Debes N, Tárnok Z, van de Griendt J, Zimmerman-Brenner S, Murphy T.

Eur Child Adolesc Psychiatry. 2022 Oct 25. doi: 10.1007/s00787-022-02097-1. Online ahead of print.

Massive warfarin overdose management in an adolescent patient

Setiawan A, Vohra V, Winograd EJ.

Clin Toxicol (Phila). 2022 Oct;60(10):1159-1162. doi: 10.1080/15563650.2022.2116337. Epub 2022 Sep 7.

Embedded Human Closed-Loop Deep Brain Stimulation for Tourette Syndrome: A Nonrandomized Controlled Trial

Cagle JN, Okun MS, Cernera S, Eisinger RS, Opri E, Bowers D, Ward H, Foote KD, Gunduz A.

JAMA Neurol. 2022 Oct 1;79(10):1064-1068. doi: 10.1001/jamaneurol.2022.2741.

[Development and content validation of a questionnaire for functional movement disorders]

Michaelis R, Brüggemann N, Ebersbach G, Ganos C, Münchau A, Schmidt T, Weißbach A, Schlegel U, Popkirov S.

Nervenarzt. 2022 Oct;93(10):1009-1018. doi: 10.1007/s00115-021-01247-1. Epub 2021 Dec 23.

Bench to Bedside: New Therapeutic Approaches with Extracellular Vesicles and Engineered Biomaterials for Targeting Therapeutic Resistance of Cancer Stem Cells

Ingavle G, Das M.

ACS Biomater Sci Eng. 2022 Oct 4. doi: 10.1021/acsbiomaterials.2c00484. Online ahead of print.